SCHEMBL1012770

SCHEMBL1012770

C=CC(O)NN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9001343 0.97
SCHEMBL6696607 0.72
SCHEMBL724588 0.72
SCHEMBL4058497 0.69
SCHEMBL11808324 0.69
SCHEMBL88926 0.69
SCHEMBL7153578 0.67
SCHEMBL461839 0.67
SCHEMBL6059534 0.67
SCHEMBL8776554 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113302171-A Hydrazine compositions with reduced vapor toxicity 航天喷气发动机洛克达因股份有限公司 2021-08-24 CN claimed
CN-104910035-B A kind of method that hydroxyalkyl amide is catalyzed and synthesized with supported solid 南京理工大学 2017-03-15 CN claimed
CN-104910035-A Method for catalytic synthesis of hydroxyalkylamide by using loaded solid alkali UNIV NANJING SCIENCE & TECH 2015-09-16 CN claimed
CN-100384847-C Adenosine a2a receptor antagonists SCHERING CORP (US) 2008-04-30 CN claimed
CN-1800186-A Adenosine a2a receptor antagonists SCHERING CORP (US) 2006-07-12 CN claimed
US-7067655-B2 preparation of furanyl, thienyl, pyridyl, pyridyl N-oxide, oxazolyl, phenyl, pyrrolyl or C4-C6 cycloalkenyl- substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine adenosines prepared from 2-amino-4,6-dihydroxypyrimidine, POCl3 and dimethylformamide SCHERING CORPORATION (US) 2006-06-27 US claimed
EP-1283839-B1 ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORP (US) 2005-04-20 EP claimed
US-20050026932-A1 Adenosine A2a receptor antagonists SCHERING CORPORATION 2005-02-03 US claimed
WO-2004099299-A2 POROUS POLY(ARYL ETHER KETONE) MEMBRANES, PROCESSES FOR THEIR PREPARATION AND USE THEREOF POROGEN CORPORATION (US) 2004-11-18 WO claimed
US-20040222169-A1 Blending of polyether ketone polymers with polyimides, then shaping, depolymerization and removal of polyimide monomers, to form porometric materials such as sheets, tubes or fibers used for filtration or adsorption MASSACHUSETTS DEVELOPMENT FINANCE AGENCY 2004-11-11 US claimed
US-20040023997-A1 Adenosine A2a receptor antagonists MERCK SHARP & DOHME CORP. 2004-02-05 US claimed
CN-1451007-A Adenosine A2aReceptor antagonists SCHERING CORP (US) 2003-10-22 CN claimed
EP-1283839-A1 ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2003-02-19 EP claimed
US-20020099061-A1 Adenosine A2a receptor antagonists MERCK SHARP & DOHME CORP. 2002-07-25 US claimed
WO-2001092264-A1 ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2001-12-06 WO claimed
CN-1003301-B Chemical Purification Method of Ethylene Oxide 浙江大学 1989-02-15 CN claimed
CN-86103366-A The chemical purification method of oxyethane 1987-01-24 CN claimed
US-4524006-A Selected alkylhydrazine and hydroxyalkylhydrazine adducts of diisocyanates and their use as antioxidants OLIN CORPORATION (US) 1985-06-18 US claimed
US-11878284-B2 Mesoporous poly (aryl ether ketone) hollow fiber membranes and use thereof in mass transfer processes Avanpore LLC (US) 2024-01-23 US disclosed
US-3957762-A CENTRAL NERVOUS SYSTEM DEPRESSANTS E. R. SQUIBB & SONS, INC. (US) 1976-05-18 US disclosed